Clozapine Tablets USP, 100 mg, 500 count bottles, Rx only, Manufactured in Israel by: TEVA PHARMA...

FDA Recall #D-0096-2018 — Class II — November 9, 2017

Recall #D-0096-2018 Date: November 9, 2017 Classification: Class II Status: Terminated

Product Description

Clozapine Tablets USP, 100 mg, 500 count bottles, Rx only, Manufactured in Israel by: TEVA PHARMACEUTICALS IND, LTD, Jerusalem Israel, Manufactured For: TEVA PHARMACEUTICALS USA, North Wales, PA, NDC 00093-7772-05

Reason for Recall

Failed Tablet/Capsule Specifications; potential presence of broken tablets.

Recalling Firm

Teva Pharmaceuticals USA — North Wales, PA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

3,870 bottles

Distribution

Nationwide

Code Information

Lot # 39C192, exp 06/2019

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated